Document Detail

Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study.
MedLine Citation:
PMID:  22742987     Owner:  NLM     Status:  Publisher    
BACKGROUND: Extended-spectrum beta-lactamases (ESBLs) are an increasingly important cause of resistance in Gram-negative bacteria throughout the world. AIM: We investigated the clinical and molecular epidemiology of infections caused by ESBL-producing Enterobacteriaceae in a UK hospital, to identify the types of ESBL produced and risk factors for acquisition. METHODS: Between July 2008 and June 2009, all patients yielding ESBL-producing Enterobacteriaceae from any clinical specimen were prospectively investigated using a questionnaire. API20E was used for bacterial identification; susceptibility testing and ESBL production were assessed by BSAC disc diffusion and cefpodoxime-clavulanate synergy tests, respectively. Polymerase chain reaction was used to screen a subset of isolates for bla(CTX-M) genes, to assign Escherichia coli isolates to their phylogenetic groups, and to identify members of the uropathogenic ST131 lineage. RESULTS: The overall prevalence of ESBL producers among clinical samples yielding Enterobacteriaceae was 1%; ESBL producers, obtained from 124 patients, were E. coli (N = 105), Klebsiella pneumoniae (N = 12), and others (N = 7). The main risk factors identified include recent antibiotic use (93%) and presence of a urinary catheter (24%). CTX-M group 1 ESBLs dominated (in 59 of 78, 76%, isolates studied). Most E. coli (35 of 56 tested) were phylogroup B2; of these, 23 belonged to the ST131 clone, 12 were phylogroup D, and four each belonged to phylogroups A and B1. CONCLUSION: ESBLs are an uncommon but significant problem in north-west Cambridgeshire. CTX-M-type enzymes were found in 75% of ESBL-positive isolates. All but two patients had at least one recognized risk factor. This study supports the requirement for interventions to reduce inappropriate urinary catheterization and antibiotic prescribing.
D A Enoch; F Brown; A W Sismey; D A Mlangeni; M D Curran; J A Karas; D B Cone; S H Aliyu; H Dhanji; M Doumith; S Maharjan; D Meunier; N Woodford
Related Documents :
10618087 - The 1998 senegal epidemic of meningitis was due to the clonal expansion of a:4:p1.9, cl...
22330907 - Fitness cost and interference of arm/rmt aminoglycoside resistance with the rsmf housek...
8440927 - Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus.
20021247 - Re-emergence of the progenitors of a multidrug-resistant outbreak strain of mycobacteri...
18753927 - Clade-specific hiv-1 integrase polymorphisms do not reduce raltegravir and elvitegravir...
22320687 - Bioaugmentation for polyacrylamide degradation in a sequencing batch reactor and contac...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-26
Journal Detail:
Title:  The Journal of hospital infection     Volume:  -     ISSN:  1532-2939     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8007166     Medline TA:  J Hosp Infect     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Clinical Microbiology & Public Health Laboratory, Peterborough & Stamford Hospitals NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major...
Next Document:  Categorization of real and replica objects by 14- and 18-month-old infants.